Can CJC-1295 cause joint pain?

This site's CJC-1295 citations do not measure joint pain. Two 2006 randomized trials in healthy adults estimated half-life at 5.8 to 8.1 days and found a single injection raised mean growth hormone two- to tenfold for six days or more, with IGF-1 up 1.5- to threefold for nine to eleven days. A companion study found trough growth hormone 7.5-fold higher a week later while pulse frequency and amplitude were unchanged. Those finding lines are hormone levels, not arthralgia. This FAQ does not invent a joint-pain rate the citations do not contain. Full record at /compounds/cjc-1295.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of growth hormone secretagogues. Sermorelin, tesamorelin, ipamorelin, CJC-1295, and the rest of the GHRH and ghrelin receptor family.